FERRING B.V. v. MYLAN, INC. et al
ORDERED THAT MYLAN PHARMACEUTICALS INC.'S MOTION TO TRANSFER THIS ACTION IS DENIED. IT IS FURTHER ORDERED THAT PLAINTIFF'S REQUEST FOR ITS COSTS AND FEES IN CONNECTION WITH THIS MOTION IS DENIED. ADDITIONALLY, THE PARTIES' REQUESTS FOR ORAL ARGUMENT ARE DENIED. SIGNED BY HONORABLE ROBERT F. KELLY ON 8/21/2014. 8/21/2014 ENTERED AND COPIES E-MAILED.(sg, )
IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA
MYLAN PHARMACEUTICALS INC.,
AND NOW, this
day of August, 2014, upon consideration of the
Defendant Mylan Pharmaceuticals Inc.’s Motion to Transfer this Action to the U.S. District
Court for the Northern District of West Virginia Pursuant to 28 U.S.C. § 1404 (a) (Doc. No. 53),
and Ferring B.V.’s Opposition to Mylan Pharmaceuticals Inc.’s Motion to Transfer (Doc. No.
56), it is hereby ORDERED that the Motion is DENIED.
IT IS FURTHER ORDERED that Plaintiff’s request for its costs and fees in
connection with this motion is DENIED. Additionally, the parties’ requests for oral argument
are DENIED. See E. D. Pa. Loc. R. 7.1(f) (stating that the court may dispose of a motion
without oral argument).
BY THE COURT:
/s/ Robert F. Kelly
ROBERT F. KELLY
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?